| Product Code: ETC7212317 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Antimicrobial Resistance Diagnostics Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 France Antimicrobial Resistance Diagnostics Market - Industry Life Cycle |
3.4 France Antimicrobial Resistance Diagnostics Market - Porter's Five Forces |
3.5 France Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 France Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.7 France Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 France Antimicrobial Resistance Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antimicrobial-resistant infections in France |
4.2.2 Growing awareness among healthcare professionals and patients about the importance of antimicrobial resistance diagnostics |
4.3 Market Restraints |
4.3.1 High cost associated with antimicrobial resistance diagnostics tests |
4.3.2 Limited access to advanced diagnostics technologies in certain regions of France |
5 France Antimicrobial Resistance Diagnostics Market Trends |
6 France Antimicrobial Resistance Diagnostics Market, By Types |
6.1 France Antimicrobial Resistance Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Microbiology Culture, 2021- 2031F |
6.1.4 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Immunoassay, 2021- 2031F |
6.1.5 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F |
6.1.6 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By NGS, 2021- 2031F |
6.1.7 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Mass Spectrometry, 2021- 2031F |
6.1.8 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Rapid & Point of Care, 2021- 2031F |
6.2 France Antimicrobial Resistance Diagnostics Market, By Pathogen |
6.2.1 Overview and Analysis |
6.2.2 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Streptococcus Pneumoniae (DRSP), 2021- 2031F |
6.2.3 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Campylobacter (DRC), 2021- 2031F |
6.2.4 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Clostridium Difficile (CD), 2021- 2031F |
6.2.5 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Methicillin Resistant Staphylococcus Aureus (MRSA), 2021- 2031F |
6.2.6 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Neisseria Gonorrhoeae (DRNG), 2021- 2031F |
6.2.7 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Salmonella (DRNTS), 2021- 2031F |
6.3 France Antimicrobial Resistance Diagnostics Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.5 France Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 France Antimicrobial Resistance Diagnostics Market Import-Export Trade Statistics |
7.1 France Antimicrobial Resistance Diagnostics Market Export to Major Countries |
7.2 France Antimicrobial Resistance Diagnostics Market Imports from Major Countries |
8 France Antimicrobial Resistance Diagnostics Market Key Performance Indicators |
8.1 Percentage increase in the adoption of rapid diagnostic tests for antimicrobial resistance |
8.2 Number of healthcare facilities implementing antimicrobial stewardship programs |
8.3 Rate of accuracy in antimicrobial resistance diagnostics testing |
9 France Antimicrobial Resistance Diagnostics Market - Opportunity Assessment |
9.1 France Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 France Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.3 France Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 France Antimicrobial Resistance Diagnostics Market - Competitive Landscape |
10.1 France Antimicrobial Resistance Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 France Antimicrobial Resistance Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here